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Abstract
Tissue and duct hypertension is considered as a major factor in the etiology of pain in patients with chronic pancreatitis (CP).
Duct dilatation is a consequence of duct obstruction due to scars or duct stones. Nevertheless, the procedure of choice,
drainage or resection, is still under discussion. We present long-term results of patients operated with duodenum-preserving
pancreatic head resection (DPPHR) combined with a Partington-Rochelle duct drainage in cases of chronic pancreatitis with
multiple stenosis and dilatation of the side ducts.
Methods and patients. From April 1982 to September 2001, in 55 out of 538 patients with chronic pancreatitis, a DPPHR
with additionally Partington-Rochelle duct drainage was performed (44 male, 11 female, mean age 45.8 years). Ninety-two
percent of the patients suffered from alcoholic pancreatitis. Medical respective pain treatment for chronic pancreatitis was in
median 64.5 months prior to surgery. The indications for surgery were in 87% pain, 59% of the patients had an inflammatory
mass in the head of the pancreas, 36% a common bile duct stenosis and 5% a severe stenosis of the duodenum. The endocrine
function (OGGT) was impaired in 79% of the patients preoperatively.
Results. Hospital mortality was 0%, postoperative complications occurred in 11 patients. Follow-up: All except 2 patients
were followed up in the outpatient clinic with the mean follow-up time of 69.7 months (8–105 months), the late mortality was
9%. Sixty-eight percent of the patients were completely free of pain, 29% had occasional pain, 3% suffered from a further
attack of pancreatitis. Body weight increased in 79%, 58% were professionally rehabilitated. Late postoperative endocrine
function was unchanged in 85% (improved in 5%, deteriorated in 10%).
Conclusion. The pain control in patients with multiple duct stenosis after duodenum-preserving pancreatic head resection
with duct drainage leads to long-standing absence of pain and low recurrence rate of attacks of pancreatitis.
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Introduction
Chronic pancreatitis is a disease of progressive
inflammation of the exocrine tissue, which is caused in
Western countries mainly by continuous alcohol
abuse. According to a recently established hypothesis,
chronic pancreatitis results from relapsing acute
pancreatitis that causes interstitial acinar and fatty
tissue necrosis, inducing a perilobular fibrosis, and
consequently results in stenoses and dilatations of the
pancreatic main duct. In about 30%–50% of the
patients with chronic alcoholic pancreatitis an in-
flammatory mass in the head of the pancreas de-
velops, leading to a head enlargement. Besides local
complications (such as stenosis of the pancreatic main
duct, the common bile duct or the duodenum) the area
of inflammation leads to a pancreatitis-specific neuritis
which contributes to the clinical pain syndrome via
local release of pain hormones, such as substance P and
CGRP [1,2].
Drainage operations are performed as a lateral side-
to-side pancreaticojejunostomy, first described by
Partington and Rochelle [3]. The combination of
drainage operations with distal pancreatectomy as
described by Puestow and Gillesby [4] has been aban-
doned because of the disadvantage of an unnecessary
pancreatic left resection. In the Partington-Rochelle
procedure the main duct is incised longitudinally
over its full length and anastomosed with a Roux-
en-Y jejunal loop. The disadvantage of this procedure
is that the inflammatory mass of the pancreas is not
treated.
In this study we present our long-term results
of patients operated with duodenum-preserving
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pancreatic head resection (DPPHR) combined with a
Partington-Rochelle duct drainage in cases of chronic
pancreatitis with multiple stenosis and dilatation of the
side ducts.
Patients and methods
Between April 1982 and September 2001, 538 patients
with chronic pancreatitis (CP) were operated with a
duodenum-preserving pancreatic head resection. In 55
of 538 patients a modification according to Partington-
Rochelle was performed for multiple stenosis and
dilatation of the pancreatic main duct (DPPHR+PR),
483 patients out of 538 were treated with a DPPHR
alone (DPPHR). The DPPHR-group of 483 patients
consisted of 382 men and 101 women with a mean age
of 46.3 years (range 18–74 years). Of the 55 patients
(DPPHR+PR), 44 patients were male, 11 female, the
mean age being 45.8 years (range 20–73 years). Pain
was measured by using the visual analog scale (VAS).
The diagnosis of CP was made using the case history
data, exo- and endocrine function tests, data of
imaging procedures and the intra-operative findings as
well as the histological investigation of operative
specimens. To evaluate the late outcome, clinical data,
endocrine and exocrine function tests as well as the
pain status were assessed pre- and postoperatively. For
measurement of the endocrine function an oral glucose
tolerance test (OGTT) and for the exocrine function a
pancreolauryl test (PLT) were carried out.
Preoperative morbidity
The mean duration of the disease since diagnosis was
64.5 months (DPPHR+PR) and 49.5 month
(DPPHR), respectively. Pain was the leading clinical
symptom of the majority of the patients: 93%
(DPPHR+PR) and 87% of the patients (DPPHR),
respectively. The etiology of pancreatitis was alcohol
consumption in 92% for patients treated with
DPPHR+PR and 84% for those with DPPHR alone.
The rate of attacks of pancreatitis since diagnosis was
similar for both groups of patients with 5.2/patient
(DPPHR+PR) and 5.5/patient in median. Previous
interventional treatment with placement of stents were
reported by 16% (DPPHR+PR) and 31% (DPPHR)
of the patients. Thirty-one percent and 29% of the
patients had surgical treatment for chronic pancreatitis
prior to DPPHR (Table I). In terms of the exocrine
function a pathological PLT-test was observed in 78%
of the patients with CP. Preoperative evaluation of
the endocrine function using the oral glucose tolerance
test showed an impaired glucose metabolism in 46%
of the patients; 33% of the patients were in the state
of insulin-dependent diabetes; 21% of the patients
were in the normal range of glucose metabolism
(Table IV).
Preoperative and intra-operative assessment
Endoscopic retrograde cholangiopancreatography
(ERCP) revealed common bile duct stenosis in 36% of
the patients; 18% had a cholestasis. Of the patients
with CP, 59% displayed an inflammatory mass in the
head of the pancreas (IMH). Five percent of the
patients showed a duodenal stenosis due to enlarge-
ment of the pancreatic head. Other morphological
alterations in the pancreatic tissue was observed as
follows: calcification 54%, duct stones 49%, pseudo-
cystic lesions 46% and areas of focal necrosis 15%.
Late follow-up
All except two patients were followed postoperatively
in the out-patient clinic. Five patients died in the
follow-up period due to: cardiac arrest (2 patients),
necrotizing pancreatitis (1 patient) and unknown
reasons (2 patients). Two patients were lost for follow-
up. The mean follow-up rate for the late follow-up
was 69.7 months (range: 8–105 months). The data
presented in the late follow-up are based on the recent
evaluation using the case history, the data from the
exocrine (PLT) and endocrine function tests (OGTT)
as well as the pain status.
Statistics
The statistical evaluation was performed using the
McNemar and the Wilcoxon test. p50.05 was
considered as significant difference.
Results
DPPHR with additional pancreatic main duct drainage
was applied to all 55 patients in the technique as
described elsewhere [5,6]. The wet weight of the
operative specimen figures between 25 g and 45 g.
An internal drainage of the common bile duct, as
described elsewhere, due to a stenosis in the intra-
pancreatic segment as well as a cholecystectomy was
performed in 31% of the patients [5,6]. In two patients
with a duodenal stenosis a decompression of the
Table I. CP with and without pancreatic main duct dilatation—
preoperative morbidity (538 patients*)
DPPHR**
483 patients
DPPHR+PR***
55 patients
Duration of disease (months) 49.5 64.5
Pancreatitis periods (years/patient) 1.5 2.2
Peroperative surgical procedures 29% 31%
Stent common bile duct 26% 13%
Stent pancreatic main duct 5% 3%
*April 1982–September 2001 Department of General Surgery,
University of Ulm, Germany.
**DPPHR: Duodenum-preserving pancreatic head resection.
***DPPHR+PR: Duodenum-preserving pancreatic head resection
with Partington-Rochelle modification.
Chronic pancreatitis, pancreatic main duct dilatation 115
duodenum was sufficient for restoration of the food
transit.
Early postoperative course
The mean postoperative hospitalization time was 14.5
days (range: 7–46 days). Early postoperative morbidity
occurred in 11out of 55 patients (20%); we observed
bleeding (3 patients), pancreatic fistula (3 patients),
pleural effusions (4 patients), cardiopulmonary
dysfunction (3 patients), intra-abdominal abscess (2
patients) and sepsis (1 patient); 5 out of 55 patients
(9%) had to be re-operated because of intra-abdominal
abscess (1 patient), sepsis (1 patient), bleeding (1
patient) and anastomotic leakage (2 patients). Hospital
mortality was 0% (Table II). Concerning the endo-
crine function, as assessed by the OGTT, no significant
change was seen (data not shown). In terms of the
exocrine function, all patients received a substitution
with pancreatic enzymes because of an ongoing
exocrine functional impairment.
Late postoperative status
The follow-up period of the 48 patients was 69.7
months in median with a range of 8–105 months. Five
patients died in the late follow-up, the late mortality
being 9%. Five percent of the patients were rehospi-
talized due to periods of pancreatitis. None of the
patients needed a re-operation.
In terms of pain status in the long-term follow-up
68% of the patients were completely pain-free, the
need for analgetic treatment dropped from 64%
preoperatively to 5% postoperatively. In terms of pain
as well as concerning attacks of pancreatitis, the
decrease of the number of patients was significant from
preoperative to postoperative (p50.002) (Table III).
In terms of endocrine status, 32% of patients remained
in a normal glucose status; 68% patients showed an
impaired glucose status, 31% with impaired glucose
tolerance test and 37% with insulin-dependent
diabetes mellitus. The change in endocrine function
(preoperative to postoperative) was not significant
(Table IV). In terms of quality of life, 58% of the
patients were professionally rehabilitated; 32% were
retired. The body weight was increased in 38 out of 48
patients (79%); 32% of the patients still drank alcohol
(Table V).
Discussion
The surgical approach to management of chronic
pancreatitis has changed during the last decades mostly
due to an increase in understanding of the patho-
physiology of the disease. This led to a decrease of
drainage procedures and an increase of parenchymal
resections mostly in the pancreatic head. The most
important factors for this changing approach to surgical
management in chronic pancreatitis may be the better
understanding of pathophysiology of pain and the
reduction of morbidity and mortality of the resective
procedures in pancreatic surgery [5,7–9]. Two
hypotheses contribute to the severe pain syndrome in
chronic pancreatitis. It could be demonstrated that
sensory nerves in the area of inflammation are enlarged
in diameter and showing a loss of their perineural
sheath and infiltration of inflammatory cells [1]. The
pancreatitis-specific neuritis has been found to
contribute to the clinical pain syndrome via local
Table II. CP with pancreatic main duct dilatation—early post-
operative results (538 patients*)
DPPHR**
483 patients
DPPHR+PR***
55 patients
Postoperative
hospitalization (days)
13.9 (7–124) 14.5 (7–46)
Early postoperative
morbidity
18% 20%
Re-operation 6% 9%
Hospital mortality 0.8% 0%
*April 1982–September 2001 Department of General Surgery,
University of Ulm, Germany.
**DPPHR: Duodenum-preserving pancreatic head resection.
***DPPHR+PR: Duodenum-preserving pancreatic head resection
with Partington-Rochelle modification.
Table III. CP with pancreatic main duct dilatation—pain status after
surgery (55 patients*)
Preoperative*
55 patients
Late
postoperative**
48 patients
Pain status:
Daily 39% 3%
Occasionally 48% 29%
No pain 13% 68%***
Attacks of acute pancreatitis 53% 5%***
Analgetic treatment 64% 5%***
*April 1982–September 2001 Department of General Surgery,
University of Ulm, Germany.
** late postoperative follow-up: 53/55 patients (mean follow-up: 69.7
months (8–105 months)).
*** p50.002 (McNemar) preoperative versus postoperative.
Table IV. CP with pancreatic main duct dilatation—endocrine
status (55 patients*)
Preoperative
55 patients
Late
postoperative**
48 patients
OGTT normal 21% 32%
OGTT impaired 46% 31%
IDDM 33% 37%
*April 1982–September 2001 Department of General Surgery,
University of Ulm, Germany.
** late postoperative follow-up: 53/55 patients (mean follow-up: 69.7
months (8–105 months)).
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liberation of pain hormones like substance P and
CGRP (2). A second hypothesis suggests that the
progressive fibrosis leads to increased pressure in both
pancreatic ducts and tissue, which may lead to a kind of
pancreatic compartment syndrome due to reduced
blood flow [10–13]. Nevertheless, anatomical,
embryological and pathomorphological findings point
to the head of the pancreas as a pacemaker of the
disease, as postulated by Beger [19] and Longmire [14].
Regarding the tissue mass of the normal pancreas, the
pancreatic head including the neck up to the portal vein
covers approximately 50% of the pancreatic tissue.
Furthermore the head of the pancreas covers two
different embryological parts of the pancreas, the
dorsal and the ventral pancreas, which might influence
the pathomorphology in the pancreatic head. The
double duct system including the duct of Santorini and
the duct of Wirsung is of clinical relevance to the
pathomorphology of pancreatic inflammation. Partic-
ularly the experience with pancreas divisum demon-
strates that anomalies of the pancreatic duct system in
the head of the pancreas sometimes lead to an
inflammatory process predominantly in the head due
to obstruction of the pancreatic juice and generation of
local inflammatory process [15,16].
The most common drainage procedure is the side-
to-side pancreaticojejunostomy as described by
Partington-Rochelle [3]. However, a number of
patients are suffering from additional problems due to
an inflammatory mass in the head of the pancreas, e.g.
common bile duct stenosis, duodenal stenosis, and
vascular stenosis with compression of the portal vein
and portal hypertension. Consequently, long-term
results of drainage procedures are rather discouraging.
Whereas early postoperative results were good, they
had deteriorated during the following 5 years to 55%
good or fair pain relief [17]. In contrast to these results,
the patients presented in our series had a significant
improvement concerning their pain status in the long-
term follow-up. The proportion of patients who were
completely free of pain was 68% after a median follow-
up of 5.8 years. The need for analgetic treatment
dropped significantly from 64% before operation to
5% in the late follow-up. According to this, the number
of patients who suffered from attacks of acute
pancreatitis was reduced from 55% to 5% (preoper-
ative versus late postoperative). These data indicate
that the combination of local resection and duct drain-
age may result in a slow-down of the progression of the
disease. Markowitz et al. [18] evaluated the reasons for
failure in 15 consecutive patients 5 months after a
Partington-Rochelle operation. They re-operated on
14 out of 15 patients (13 head resections, 1 left re-
section) and followed them up for a median of 39
months. During this follow-up, 10 patients became
pain-free and 2 died of pancreatic cancer which
had been overlooked during the Partington-Rochelle
operation. The reasons for failure of the Partington-
Rochelle procedure, according to the authors, were:
pancreatic cancer, inadequate duct decompression,
biliary stenosis and inflammation of the head of the
pancreas. In summary, the single use of a drainage
operation is limited to patients without inflammatory
mass in the pancreatic head, but with dilatation of the
main pancreatic duct.
The Frey procedure has been introduced primarily
as a drainage procedure with an additional minor
resection of part of the pancreatic head and is therefore
a modified Partington-Rochelle procedure which
leaves the major part of the inflammatory mass in the
pancreatic head. In contrast to DPPHR with a weight
of the resected tissue of about 25–45 g, the Frey
procedure is a coring out of part of the pancreatic head
with an average specimen weight of less than 6 g [8].
Consequently this procedure is not effective against
cholestasis, because the resection is not appropriate to
decompress the common bile duct in the intrapan-
creatic segment.
The pathomorphological changes of CP are devel-
oping in the duct system in the pancreatic head. On the
basis of computed tomography-investigations, 59%
of the patients of this series demonstrated an inflam-
matory mass in the head of the pancreas. Pseudocystic
lesions in 46%, and biliary stenosis in 36%, underline
that the pancreatic head is the leading area in this
type of CP. Therefore an appropriate resection of the
pancreatic head is indicated.
In terms of endocrine function after DPPHR, recent
studies could demonstrate a preservation of the glucose
metabolism [19,20]. It could be shown, that the anti-
insulinary hormones glucagon and somatostatin are
reduced [21]. In this series there was a tendency
towards an improvement in the number of patients
with normal endocrine function from 21% to 32%
(preoperative versus late postoperative). However, the
changes in endocrine function between the groups of
patients with normal or impaired glucose metabolism
showed no statistically significant changes (Table IV).
Lankisch et al. observed a normal endocrine function
in alcoholic CP in only 17% of the patients; 81% of
the patients had moderate or severe endocrine insuf-
ficiency [22].
Table V. CP with pancreatic main duct dilatation—quality of life
after surgery (55 patients*)
Late postoperative**
48 patients
Pain free 68%
Professional
rehabilitation 58%
retired 32%
Increased body weight 79%
Enzyme supplementation 72%
Alcohol intake 32%
*April 1982–September 2001 Department of General Surgery,
University of Ulm, Germany.
** late postoperative follow-up: 53/55 patients (mean follow-up: 69.7
months (8–105 months)).
Chronic pancreatitis, pancreatic main duct dilatation 117
In terms of quality of life, 79% of the patients showed
a significantly improved body weight. Fifty-eight
percent of the patients were able to return to work,
32% had already retired. Nevertheless, 10% of the
patients in the follow-up were still unable to return to
work.
After DPPHR the death rate was 9% in a mean
observation time of 5.8 years. In studies with a
comparable observation time the death rate was
between 20% and 35% [22–24]. In two studies
following lateral pancreaticojejunostomy for CP, the
death rate was reported at 21% and 26%, respectively
[17,25]. The death rate was considered to be caused by
continuing alcohol abuse or late complications in more
than 50% of the patients [17]. In comparison to
subtotal resection of the pancreatic head, drainage
procedures bear the risk of overlooking a malignant
lesion [26,27]. Lucas et al. [28] reported a death rate of
8% (10 patients), whereas at least 6 patients (5%) died
of pancreatic cancer. Haas et al. [29] reported an
increased frequency of pancreatic cancer after
pancreaticojejunostomy. This cancer was far advanced
in all cases. Lowenfels et al. [30] noted in multi-center
study an increased risk of developing pancreatic cancer
in chronic pancreatitis patients. Regarding the signifi-
cant association between alcoholic chronic pancreatitis
and pancreatic cancer, DPPHR may have a preventive
effect in terms of the development of pancreatic head
cancer in patients with inflammatory mass and
pancreatic main duct dilatation.
Conclusion
Upper abdominal pain and pancreatitis attacks are the
leading symptoms of patients suffering from CP with
pancreatic main duct dilatation. The most common
drainage procedure is the side-to-side pancreatico-
jejunostomy as described by Partington-Rochelle
which is designed for patients with duct dilatation
without additional problems due to an inflammatory
mass in the head of the pancreas, e.g. common bile
duct stenosis, duodenal stenosis, and vascular stenosis
with compression of the portal vein and portal hyper-
tension. That may be one reason, why long-term
results of drainage procedures are rather discouraging.
Whereas early postoperative results are good, they
deteriorate during the following years. In contrast to
these results, the patients presented in our series had a
significant improvement concerning their pain status in
the long-term follow-up. The number of patients who
were completely free of pain was 68% after a median
follow-up of 5.8 years. The number of patients who
suffered from attacks of acute pancreatitis was reduced
from preoperatively 55% to 5% postoperatively. These
results indicate that the combination of local resection
and duct drainage may result in a slow-down of the
progression of the disease. Duodenum-preserving
pancreatic head resection furthermore preserves the
endocrine function in the early and late postoperative
course. The duodenum-preserving head resection has
a low early and late morbidity and surgical-related
mortality. In comparison to drainage procedures in
CP, subtotal resection of the pancreatic head mini-
mizes the risk of overlooking a malignant lesion.
DPPHR should be the surgical procedure of choice in
patients with multiple duct stenosis regarding the
favourable short-term and beneficial long-term
outcome.
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